RecoupIQ provides business intelligence from public UK records. Nothing here constitutes financial advice, a regulated credit assessment, or a regulated activity under FSMA 2000. Evidence indicators summarise available records and are not credit decisions. ICO ZC077511. Privacy · Terms · Corrections

Company profileActive

NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR)

Name: NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) Company Evidence Check
Brand: RecoupIQ
Price: 29 GBP
Availability: InStock

Companies House #02165552LIVERPOOLIncorporated 1987-09-16

This page keeps the public record visible while making the next decision clear. It confirms the legal entity, shows the current evidence posture, and points you to the deeper check only when you need it.

Confirm legal entity

Check the number and registered office before you rely on this page.

Registered office: ROOM G6 LIVERPOOL SCIENCE PARK, LIVERPOOL, L3 5TF, ENGLAND, L3 5TF

Companies House number

02165552

Open official source

Published profile snapshot date: 15 Oct 2026. This page shows selected public evidence, not a guarantee of payment or solvency.

Active

Companies House record

39 years

Since 1987-09-16

Public signals

1 selected signal

Displayed checks only

Get Quick Check · £29 Forensic Report · £167.00 Monitor Free Alerts

Verified Public Records • Free Statutory Snapshot

Statutory Registry & Solvency Facts

Core statutory intelligence compiled from Companies House, filed iXBRL statutory accounts, and the register of charges.

Companies House #02165552

Board Governance & Corporate Identity History

Active Directors1Registered officers

Resignations (12m)0Stable board tenure

Address Moves (24m)0Stable registered office

Amber
evidence state

Available public evidence

Evidence posture: Review in available public evidence

Amber means selected public-record signals deserve verification before a material decision. Scale: red means non-normal status, and green means no selected warning found. It is not a credit score or payment prediction.

Recommended next step: Verify the selected signals before increasing credit, committing spend, or extending terms.

Warning Signals Identified

Accounts appear overdue

Selected public-record signals from 15 Oct 2026; verify current source and context before acting.

Before you commit

Decision support document

Need a decision, not another directory page?

The Quick Check turns this public record into a source-linked PDF with the evidence available, the warning signals that deserve attention, and the exact questions to verify before extending credit or signing contracts.

£29 one-off

What the record shows

Verified filings, accounts & charges

What to verify next

Recommended checks & protective terms

Select report depth (instant 1-click checkout · no account required)

Forensic Report, £167.00

Make a better-informed decision about NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR)

We pull deeper public-record evidence the moment you order: director history, connected companies, filed accounts, charges, sector context, and source-linked findings. Use the report to decide what to verify, what terms to discuss, and when to review the relationship. PDF in your inbox within minutes.

See a sample report →

“This product I found excellent, delivered exactly what I wanted and in a timely manner too.”

Elvis Serkedi · Trustpilot

Checking 2+ companies or clients? RecoupIQ Pro (£149/mo) is £18 less than a single £167.00 Forensic Report.Compare Pro (£149/mo) →

Check first. Get change alerts for this company, free.

We read the registers daily. If NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) files an insolvency notice, picks up a Gazette entry, or its public-record position changes, you’ll know the same day.

Used only to send change alerts about this company, for 90 days. One-click unsubscribe in every email. No marketing.

Companies House Officer Record

Current Officers

13 registered

ANANTHARAMAN, SANDEEP

director · Appointed 2022-04-28

BARTON, KERI

director · Appointed 2025-01-30

BOWERS, JENNY

director · Appointed 2025-01-30

CARTER, MICHAEL FITZGERALD

director · Appointed 2020-02-10

Statutory Register Records

Identity & Statutory Filings

Company Status

Active

Company Type

PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption)

Incorporated

1987-09-16(39 yrs)

Registered Office Address

ROOM G6 LIVERPOOL SCIENCE PARK, LIVERPOOL, L3 5TF

Industry Classification (SIC)

86900 - Other human health activities

Filing Deadlines & Compliance Status

Last Accounts Filed

2024-09-30(GROUP)

Accounts Next Due

Overdue

Evidence Boundary

What this Public Dossier Shows & Evidence Limits

Filed financial snapshotNot available in public record snapshot. Treat the gap as unknown, not clear.

Official payment-practice returnNot available in public record snapshot. Treat the gap as unknown, not clear.

Corporate relationshipsNot available in public record snapshot. Treat the gap as unknown, not clear.

Source-backed visual

Evidence availability by module

Each bar shows the module contribution available in this published profile. A missing bar is an evidence gap, not a favourable result.

Official status

25% of coverage measure

Available

Registered address

Forensic Overview

Company Narrative & Historical Synthesis

NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) is a long-established pri/lbg/nsc (private, limited by guarantee, no share capital, use of 'limited' exemption) based in LIVERPOOL, incorporated in September 1987 and 39 years on the register. Its primary registered activity is other human health activities.

Filing obligations show a concern: accounts are overdue at Companies House (last filed 24 months ago as group accounts), and the confirmation statement is up to date.

On charges and ownership: no charges are registered at Companies House; no PSC records on the public register.

Public-register risk signals for NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR): traded previously as CLATTERBRIDGE CANCER RESEARCH; CLATTERBRIDGE CANCER RESEARCH TRUST.

A paid RecoupIQ report for NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) adds a source-linked review of the available evidence and a prioritised verification plan, delivered as a PDF within minutes.

Source: Companies House public register, filed accounts (iXBRL), The Gazette, and HMRC. Synced daily.

Continuous Due Diligence

Need to check another UK company?

Search across 5.4 million registered UK companies for insolvency petitions, Gazette notices, CCJs, and director cross-directorships in real time.

Knowledge Base & Diligence FAQ

Frequently Asked Diligence Questions

Is NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) safe to trade with?

The RecoupIQ evidence view summarises available Companies House filings, The Gazette, the HMRC defaulters register, and director-network evidence in the other human health activities sector. A paid report gives you the source-linked detail behind each selected signal.

How do I check NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) payment history?

NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR)'s accounts are currently overdue at Companies House, which can indicate cash-flow difficulty. The free page shows the latest filed accounts date and whether filings are overdue. It does not establish actual trade payment history. A Forensic Report (£167.00) can add filed financial ratios, trade-debtor and cash-position signals, public-register notices, and other available evidence. Order it above and it arrives in your inbox within minutes.

Legal Methodology & Evidence Integrity

How we work this out. Every claim is built from public UK records: Companies House (filings, officers, charges register), filed accounts (XBRL), The Gazette corporate-insolvency notices, and HMRC’s Public Deliberate Defaulters register. Paid analysis may add derived filing, financial, network, and continuity context where the underlying evidence is available. Derived outputs are labelled with their inputs, source dates, and limitations; they are not guarantees of payment or regulated credit decisions. Source data is published under the Open Government Licence v3.0.

Honest opinion. Aggregate signals only. Specific named claims about still-trading companies are framed as percentile and evidence-based observation under the Defamation Act 2013 §3 honest-opinion defence. Right of reply: any company can email contact@recoup-iq.tech with corrections to filed data.

Verify these facts on Companies House Forensic Report

Controlling PSC entities

Previous legal names: CLATTERBRIDGE CANCER RESEARCH (until 2012-11-05); CLATTERBRIDGE CANCER RESEARCH TRUST (until 2010-01-28)

Need complete cross-director insolvency & solvency tracking?

Unlock the source-linked Quick Check (£29) or full Forensic Dossier (£167.00) with director dissolution histories, connected-company contagion, and credit decision guidance.

Quick Check · £29 →Forensic · £167.00

Verify the selected warning. Accounts appear overdue. Confirm the source, date, and context before acting.

Request current financial evidence. Public filed figures are not available on this page. Request current management accounts when exposure is material.

Confirm payment terms directly. Public payment-practice evidence is not available here. Agree limits, terms, and a review date directly.

Evidence availability score

70/ 100

Partial evidence set. 4 of 7 defined modules assessed. This is not a credit score, probability of default, or clearance to trade. Source: 15 Oct 2026.

Evidence to verify or obtain: Filed financial snapshot, Official payment-practice return, Corporate relationships.

Permanent PDF record

Delivered to your email in minutes

Frequently asked buyer questions

Is this a credit score?

No. The traffic light describes available public evidence and selected warnings. It is not a probability of default, payment guarantee, or clearance to trade.

What if data is missing?

Missing evidence stays visible as a coverage limit. It cannot become a green result, and the report states what should be verified elsewhere.

What do I receive?

One source-linked PDF for this company, with findings, evidence dates, questions to verify, and terms to discuss. Delivery is within minutes of purchase.

Get the Quick Check £29 See sample report previewOne company · PDF delivered within minutes · No subscription required

CLAGUE, JOANNE LOUISE

director · Appointed 2023-04-26

EDLER, JULIE KAREN

director · Appointed 2025-01-30

GILES, SUSAN

director · Appointed 2025-01-30

HEWISON, FRANCES

director · Appointed 2022-04-28

KOTHARI-SHORT, SHARVARI

director · Appointed 2020-02-10

MOONAN, PAUL EDMUND

director · Appointed 2022-04-28

RICHARDS, ALASTAIR DAVID

secretary · Appointed 2017-04-20

STALKER, ANDREW PHILIP

director · Appointed 2022-04-28

WILLIS, JOHN

director · Appointed 2022-04-28

Source: RecoupIQ's current Companies House officer snapshot. Use the source link below to check that these facts match the official register. A paid report can add full appointment history, prior companies, and network connections.

Confirmation Statement

Due 2027-03-17

Last filed 2026-03-03

Accounts Age

Filed 24 months ago

Previously Known As

CLATTERBRIDGE CANCER RESEARCHChanged 2012-11-05

CLATTERBRIDGE CANCER RESEARCH TRUSTChanged 2010-01-28

10% of coverage measure

Filing record

20% of coverage measure

Available

Confirmation statement

15% of coverage measure

Available

Filed financial snapshot

15% of coverage measure

Not available

Official payment-practice return

10% of coverage measure

Not available

Corporate relationships

5% of coverage measure

Not available

Source: published public-record profile. Profile date: 15 Oct 2026. Coverage availability only, not a credit score.

The 70/100 score measures evidence availability only. Missing evidence is not treated as low risk. Published snapshot date: 15 Oct 2026.

Is NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) a legitimate company?

NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) is an active company, 39 years on the Companies House register. The free evidence page above covers the current filing position, company type, and registered address. A paid report adds director history, network context, and other available analytical outputs with their limitations.

What does a RecoupIQ Forensic Report cover for NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR)?

The Forensic Report (£167.00) runs NORTH WEST CANCER RESEARCH (INCORPORATING CLATTERBRIDGE CANCER RESEARCH CCR) (02165552) through available director-network and prior-failure history, filed accounts analysis, phoenix-pattern detection, HMRC defaulters checks, Gazette insolvency notices, charge-register evidence, and sector context in the other human health activities sector. Results are cited back to the underlying public record and labelled when evidence is limited. PDF delivered to your inbox within minutes.

Check Another Company

Verify another UK debtor, supplier, or counterparty.